NCT05446753

Brief Summary

The overall aim of this randomized controlled trial is to investigate the effects of consuming a Plant-Based Meat alternative Diet (PBMD) compared to an Animal-Based Meat Diet (ABMD) on cardiometabolic health and protein homeostasis in Chinese men and women in Singapore. This will be achieved through the following specific objectives: (1) To evaluate the effects of dietary protein source on metabolic health and glycemic control(2) To evaluate the effects of dietary protein source on risk factors of cardiovascular diseases (3) To evaluate the effects of dietary protein source on protein homeostasis and metabolism.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 17, 2022

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 23, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 7, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

July 7, 2022

Status Verified

July 1, 2022

Enrollment Period

11 months

First QC Date

June 23, 2022

Last Update Submit

July 4, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in metabolic health risk indicators

    Glucose

    Pre- and Post-intervention (Week 8)

  • Change in cardiovascular health risk indicators

    Insulin

    Pre- and Post-intervention (Week 8)

  • Change in metabolic health risk indicators

    Fructosamine

    Pre- and Post-intervention (Week 8)

  • Change in metabolic health risk indicators

    14-day continuous blood glucose monitoring (subgroup; n = 48)

    Day -2 (from Week 0) to Day 12. 14 days in total

  • Change in cardiovascular health risk indicators

    Total cholesterol, LDL-cholesterol, HDL-cholesterol, Triglycerides

    Pre- and Post-intervention (Week 8)

  • Change in cardiovascular health risk indicators

    Clinic blood pressure and ambulatory blood pressure (subgroup; n = 48)

    Pre- and Post-intervention (Week 8)

Secondary Outcomes (8)

  • Change in protein metabolism-related biomarkers in plasma/serum

    Pre- and Post-intervention (Week 8)

  • Change in protein metabolism-related biomarkers in plasma/serum

    Pre- and Post-intervention (Week 8)

  • Change in protein metabolism-related biomarkers in plasma/serum

    Pre- and Post-intervention (Week 8)

  • Change in protein metabolism-related biomarkers in plasma/serum

    Pre- and Post-intervention (Week 8)

  • Change in inflammation-related risk indicators

    Pre- and Post-intervention (Week 8)

  • +3 more secondary outcomes

Study Arms (2)

Animal-based meats (ABMD group)

EXPERIMENTAL

Participants will be instructed to substitute protein-rich foods consumed habitually with animal-based meats (ABMD group).

Dietary Supplement: Animal-based meats

Plant-based meat alternatives (PBMD group)

EXPERIMENTAL

Participants will be instructed to substitute protein-rich foods consumed habitually with Plant-based meat alternatives (PBMD group).

Dietary Supplement: Plant-based meat alternatives

Interventions

Animal-based meatsDIETARY_SUPPLEMENT

Animal-based meats from beef, pork and chicken

Animal-based meats (ABMD group)

Plant-based meat alternatives of beef, pork and chicken

Plant-based meat alternatives (PBMD group)

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chinese males and females
  • Age \> 30 to \</= 70 years
  • Habitually consuming between 2 and 4 servings of protein-rich foods daily (\~20 g protein per serving)
  • Raised blood glucose (fasting glucose \>/= 5.4 and \</= 7.0 mmol/L) and/or (HbA1c \>/= 5.7 and \</= 6.4 %)
  • Fully vaccinated against COVID-19 (referred to as having completed a minimum of 2 doses Pfizer-BioNTech / Comirnaty / Moderna or 3 doses Sinovac-CoronaVac)
  • Ability to give an informed consent
  • Willing to adhere to study intervention procedures

You may not qualify if:

  • Obese: BMI (\>/= 27.5 kg/m2) and/or waist circumference (\>/= 102 cm for male; \>/= 88 cm for female)
  • Significant weight change (± 5 % body weight) during the past 3 months
  • Past bariatric surgery
  • Women who are pregnant, lactating or planning pregnancy
  • History or known present diagnosis of cardiovascular (i.e.hypertension (systolic/diastolic blood pressure: \>/= 140/90 mmHg), endocrine (i.e. type 1 and type 2 diabetes mellitus), gastrointestinal, hematological (G6PD and coagulation disorders), hepatic (hepatitis B and C), malignant, renal, respiratory, thyroid or other relevant disorders which may affect the outcomes of interested in consultation with the researchers involved
  • Prescribed and regularly taking western or traditional medicine which may affect the outcomes of interest in consultation with the researchers involved
  • History or present diagnosis of HIV and/or tuberculosis.
  • Drug abuse within the last 5 years
  • Taking dietary supplements which may affect study outcomes one month prior to their first visit (e.g. protein supplements, omega-3/6 supplements or other nutritional supplements such as Ensure, Anlene etc.)
  • Following any special diets which may interfere with intervention procedures (for medical, aesthetic or religious reasons)
  • Allergy to nuts, seeds, legumes (soy, pea), cereal (wheat gluten), beef, pork, chicken or any other ingredients present in foods provided for intervention
  • Excessive alcoholic beverage consumption \> 2 servings per day (1 serving is defined as 360 mL beer, 150 mL wine or 45 mL distilled spirits)
  • Smoking (cigarette, e-cigarette, cigar, pipe) or vaping
  • Exercising vigorously over the past 3 months
  • Staff of Prince September Pte. Ltd. (Pinduoduo Inc.) and/or Singapore Institute of Food and Biotechnology Innovation (SIFBI)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Nutrition Research Centre

Singapore, 117599, Singapore

RECRUITING

Related Publications (1)

  • Toh DWK, Fu AS, Mehta KA, Lam NYL, Haldar S, Henry CJ. Plant-Based Meat Analogs and Their Effects on Cardiometabolic Health: An 8-Week Randomized Controlled Trial Comparing Plant-Based Meat Analogs With Their Corresponding Animal-Based Foods. Am J Clin Nutr. 2024 Jun;119(6):1405-1416. doi: 10.1016/j.ajcnut.2024.04.006. Epub 2024 Apr 8.

MeSH Terms

Conditions

Diabetes MellitusCardiovascular Diseases

Interventions

Meat Substitutes

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Central Study Contacts

Jeyakumar C Henry, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Executive Director

Study Record Dates

First Submitted

June 23, 2022

First Posted

July 7, 2022

Study Start

June 17, 2022

Primary Completion

May 1, 2023

Study Completion

May 1, 2023

Last Updated

July 7, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations